Susquehanna Portfolio Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5M Sell
97,454
-694,281
-88% -$81.3M 0.2% 136
2026
Q1
$95.2M Hold
791,735
1.42% 1
2025
Q4
$83.3M Hold
791,735
1.29% 1
2025
Q3
$66.5M Sell
791,735
-9,018
-1% -$743K 1.05% 4
2025
Q2
$63.4M Buy
+800,753
New +$63.7M 1.38% 3
2024
Q4
Sell
-336,782
Closed -$38.2M 213
2024
Q3
$38.2M Hold
336,782
2.61% 5
2024
Q2
$41.7M Sell
336,782
-37,300
-10% -$4.8M 1.72% 6
2024
Q1
$49.4M Hold
374,082
1.15% 9
2023
Q4
$40.8M Buy
+374,082
New +$38.8M 0.73% 15

Other funds holding MRK

Susquehanna Portfolio Strategies's MRK Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Merck (MRK) stake by 88% in Q2 2026, selling an estimated $81.3M and leaving 97,454 shares worth $12.5M. The position accounts for 0.2% of the portfolio, ranked #136.

Susquehanna Portfolio Strategies first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $95.2M in Q1 2026. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Susquehanna Portfolio Strategies held 97,454 shares of Merck worth $12.5M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 694,281 Merck shares in Q2 2026, an estimated $81.3M.
  • Merck made up 0.2% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #136 holding.
  • Susquehanna Portfolio Strategies first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Susquehanna Portfolio Strategies's Merck position peaked at $95.2M in Q1 2026.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.